SecBot SecBot
SECBOTREPLAY Home › Report › BCAX

BCAX · Bicara Therapeutics executives Claire Mazumdar (CEO) and Ryan Cohlhepp…

Bicara Therapeutics Inc. · CLUSTER filed Apr 14, 2026 at 20:00 ET

At the news

BEARISHIMPACT 7/10

CLUSTER filed Apr 14, 2026 at 20:00 ET

Bicara Therapeutics executives Claire Mazumdar (CEO) and Ryan Cohlhepp (President/COO) sold a combined $538,203 worth of shares in open-market transactions over a 6-day window. These sales follow derivative exercises and represent material insider selling by two top executives.

  • CEO Claire Mazumdar sold 15,000 shares for $354,145.50 on April 20, 2026, following multiple derivative exercises.
  • President and COO Ryan Cohlhepp sold 8,000 shares for $184,058.40 on April 15, 2026, after exercising derivatives.
  • Total open-market sales in the cluster amount to $538,203, representing approximately 0.034% of the company's $1.6B market cap.
  • Both executives exercised in-the-money options prior to selling, with some transactions involving non-cash exercises (code M).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access